Intensified & Continuous Upstream (USP) Processing
Future-proof your manufacturing strategies, reduce costs and increase facility flexibility with intensified fed-batch and perfusion processes
Biopharmaceutical developers and manufacturers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification, including intensified fed-batch and perfusion processes, can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
With a full suite of solutions designed to support the increased demands of intensified upstream processes and technical support from teams with years of experience, we can help you realize the benefits of upstream process intensification without compromising clinical milestones or speed to market.
Upstream Processing in the Facility of the Future
Intensified upstream processing is just the start of the evolution to the facility of the future. Our solutions for intensified or continuous downstream technologies enable further gains in manufacturing efficiency and flexibility, in addition to supporting the transition to fully closed processing. To further support intensification efforts and transition into next-generation bioprocessing facilities, these systems also offer best-in-class process analytical technology (PAT) tools to monitor and control critical process parameters. With next-generation automation and control capabilities, such as our Bio4C ACE™ software, automation of these systems can now be achieved in a secure, intuitive, and precise manner. Smart data management systems accelerate insights and actions in your process, enabling manufacturers to make the most out of the process data collected
Related Categories
With our comprehensive portfolio, you can choose from tried-and-true formulations...
Mobius® products and solutions can help you meet your evolving cell culture needs...
Perfusion operations deliver high-density cell cultures that alleviate the burden of processing large production bioreactor...
Related Articles
- Datasheet: Mobius® iFlex Bioreactor
The Mobius® iFlex Bioreactor is a scalable family of next generation high-performance single-use modular bioreactors for fed-batch and perfusion processes, ranging from 50 L to 2000 L, and suitable for process development and commercial manufacturing.
- Datasheet: Mobius® Breez Microbioreactor
The Mobius® Breez Microbioreactor is a 2 mL automated single-use perfusion cell culture platform designed to support gentle, adaptable, and reproducible cell processes. The system is capable of accelerating a range of applications such as cell line development, media screening and optimization, and early process development.
Related Webinars
Explore the use and benefits of a high cell density cryopreservation (HCDC)
Intensified upstream bioprocesses are being developed to increase productivity while...
BioContinuum™ Platform: Your enabler of the biomanufacturing facility of the future!
若要繼續閱讀，請登入或建立帳戶。
還沒有帳戶？